EcoDrugPlus

Adrenoceptor Beta 3a

Ensembl ID : ENSDLAG00005021477
Gene Symbol: ADRB3A
1 Cross references
197 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSDLAG00005017792
Gene Symbol: AOC1
1 Cross references
233 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSDLAG00005009169
Gene Symbol: APP
1 Cross references
206 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSDLAG00005022649
Gene Symbol: AR
1 Cross references
214 Possible Orthologues:

Arachidonate 12-Lipoxygenase

Ensembl ID : ENSDLAG00005008788
Gene Symbol: ALOX12
1 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase A

Ensembl ID : ENSDLAG00005014207
Gene Symbol: ALOX5A
1 Cross references
212 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Activating Protein

Ensembl ID : ENSDLAG00005023843
Gene Symbol: ALOX5AP
1 Cross references
201 Possible Orthologues:

Arginine Vasopressin Receptor 1aa

Ensembl ID : ENSDLAG00005023514
Gene Symbol: AVPR1AA
1 Cross references
203 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSDLAG00005022761
Gene Symbol: AVPR2
1 Cross references
210 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSDLAG00005000303
Gene Symbol: BACE1
1 Cross references
221 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1c Subunit

Ensembl ID : ENSDLAG00005019091
Gene Symbol: CACNA1C
1 Cross references
215 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1d Subunit, A

Ensembl ID : ENSDLAG00005009357
Gene Symbol: CACNA1DA
1 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).